Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-06

Clinical Trial Update: Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for RVT-501 in adults and adolescents with atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RVT-501

Snippet

Sponsor: Dermavant Sciences GmbH | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED